Military Metals Corp. secured a four-year extension of its Trojárová Antimony-Gold Project exploration license in Slovakia, valid until October 18, 2030, after a previous cancellation was overturned. The project holds significant inferred resources, including 67,000 tonnes of antimony and 222,000 ounces of gold. This extension resolves prior uncertainties and allows the company to advance exploration and development with a focus on environmental responsibility and local community engagement. Military Metals plans to collaborate with local authorities and scientific institutions to support sustainable mining practices and contribute to Europe's critical raw materials supply.
Military Metals' license extension news provides context for readers interested in basic materials. For readers following this sector, here is Pluang's market snapshot as of Oct 19, 2026 19:02 WIB: Among 83 priced Basic Materials stocks, 37 rose and 35 fell. Albemarle Corp. (ALB) traded at USD 96.99 with a 1-day gain of 1.58% and a typical hold time of 51 days, contrasting with Freeport-McMoRan Inc (FCX) at USD 68.51, down 1.48%, held typically for 70 days. Steel Dynamics Inc. (STLD) showed a price of USD 244.01, up 1.44%, but with a much shorter typical hold time of 10 days.
Bill Gross, a serial entrepreneur behind over 175 companies, has launched Idealab.ai, a platform using AI to generate and share over 1.2 million business ideas based on real-world problems. The platform aims to lower barriers to entrepreneurship by h...
The Portnoy Law Firm has launched an investigation into Cardinal Infrastructure Group for possible securities fraud following the company's Q2 2026 financial report. Cardinal revealed a decline in its gross profit margin to 10.8%, down from 13.9% the...
AIOS Tech Inc. announced an agreement to acquire SmartCore Holdings Limited in an all-stock transaction valued at approximately $100 million. The deal will issue 33.3 million AIOS shares to SmartCore's sellers, who will hold about 80% of AIOS shares ...
XBiotech announced positive results from the Phase II TASKIN trial, where their antibody vilamakitug combined with standard chemotherapy improved 12-month overall survival to 61.3% in refractory metastatic colorectal cancer patients, surpassing the s...
Proof and Circle Internet Group demonstrated a new system where AI agents can prove the identity of the person they represent using Proof's x401 open identity protocol and pay merchants in USDC via Circle's x402 payment protocol. This innovation addr...
